Pioneering nucleic acid breakthroughs for the world

Nucleic Acid Insights 2024; 1(1), 37–41

DOI: 10.18609/nai.2024.007

Published: 23 February
Interview
Robert Langer


The COVID-19 mRNA vaccines amply demonstrated the potential of nucleic acid-based medicines to reshape healthcare on a truly global basis. David McCall, Senior Editor, Nucleic Acid Insights, speaks to Robert Langer, David H Koch Institute Professor, Massachusetts Institute of Technology, about building on his enormous legacy as a founding father of nucleic acid delivery by enabling worldwide patient access to novel vaccines and therapeutics alike.